Login to Your Account



Nastech Gets Approvable Letter For Nascobal Spray

By Aaron Lorenzo


Tuesday, November 2, 2004
Nastech Pharmaceutical Co. Inc.'s reformulated treatment for vitamin B-12 deficiency, Nascobal (cyanocobalamin) Nasal Spray, received an approvable letter from the FDA. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription